Arkuda Therapeutics logo

Arkuda Therapeutics

Discovering therapies to change the trajectory of neurodegenerative disease

18 employees · est. 2018 · Watertown, United States

VS
Entact Bio logo

Entact Bio

Creating new medicines by enhancing protein function

42 employees · est. 2019 · Watertown, United States

Arkuda Therapeutics is the older company (2018 vs 2019).

Side-by-Side Comparison

Arkuda Therapeutics Entact Bio
Founded
2018 older 2019
Headquarters
Watertown, United States Watertown, United States
Employees
18 42
Industry
Biotechnology, Health Care, Health and Wellness Biopharma, Biotechnology, Life Sciences
Funding Stage
Series B Series Unknown
Total Funding
$108.00M $121.32M
Funding Rounds
3 2
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Neurodegenerative Disease, Therapies, Progranulin, Lysosomal Biology, Medicine Development Drug Development, Proteins, DUBs, Encompass Platform, Small-molecule Drugs, Medicine Enhancement, Preclinical Stage, Deubiquitinase Biochemistry, Chemical Biology, Disease Biology, Protein Function, Treatable Diseases, Founder Expertise, Chimeric Medicines
Website
arkudatx.com entactbio.com
Arkuda Therapeutics logo

About Arkuda Therapeutics

Arkuda Therapeutics is a biotechnology company founded in 2018 and headquartered in the United States. The company's slogan, "Discovering therapies to change the trajectory of neurodegenerative disease," reflects its focus on leveraging new insights into progranulin and lysosomal biology to develop...

Entact Bio logo

About Entact Bio

Entact Bio is a biopharmaceutical and biotechnology startup founded in 2019 with a mission to develop a new class of precision medicines that enhance the function of beneficial proteins. The company's proprietary Encompass™ platform is designed to create enhancement-targeting chimeric (ENTAC™) medic...

We will tell you when either one moves

BounceWatch watches Arkuda Therapeutics and Entact Bio for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Arkuda Therapeutics and Entact Bio — by email.

Frequently Asked Questions

Arkuda Therapeutics — Discovering therapies to change the trajectory of neurodegenerative disease. Entact Bio — Creating new medicines by enhancing protein function. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Arkuda Therapeutics has raised $108.00M while Entact Bio has raised $121.32M.
Arkuda Therapeutics and Entact Bio operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Arkuda Therapeutics with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Arkuda Therapeutics on 12 Sep 2024, and Entact Bio on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy